Ocimum Biosolutions/Gene Logic Files for Chapter 11, Seeks Bidders | GenomeWeb

This article has been updated to clarify that the bankruptcy filing only applies to the Gene Logic subsidiary.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ocimum Biosolutions, doing business as Gene Logic, has filed for Chapter 11 bankruptcy protection, and is seeking a buyer for its assets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.